Published Date: 26 Apr 2023
In general, muscle function gets better during adolescence and gets worse as we get older. One such type of muscle deterioration that is primarily brought on by aging naturally is sarcopenia. Asians have lower rates of.
Read Full NewsIrreversible nerve damage to the lower limbs is a common side effect of chemotherapy, yet up to 50% of patients are missing out on vital foot care that could significantly ease their symptoms, according to new research from ...
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—the class of drugs behind Ozempic, Wegovy and Mounjaro, for example—may do more than regulate ...
Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patients live longer.
1.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
2.
recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.
3.
EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.
4.
Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
2.
Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management
3.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
4.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
5.
Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation